← Back to Search

Remote Exercise Program for Myotonic Dystrophy

N/A
Recruiting
Led By Elise Duchesne
Research Sponsored by Université du Québec à Chicoutimi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged between 18 and 60 years old
Be able to do exercise
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Study Summary

This trial is testing a new web tool that could help people with myotonic dystrophy type 1 (DM1) stay physically healthy, which is especially important during the COVID-19 pandemic.

Who is the study for?
This trial is for people aged 18-60 with confirmed Type 1 Myotonic Dystrophy (DM1) who can exercise and consent voluntarily. It's not for those who already train more than three times a week or over 150 minutes weekly, don't speak French or English, or cannot exercise even while seated.Check my eligibility
What is being tested?
The study tests the PACE tool, a web-based program offering physical activity routines tailored to DM1 patients' needs. Participants will use it daily for 12 weeks to see if it improves their physical and cognitive health without risking COVID-19 exposure.See study design
What are the potential side effects?
Since this intervention involves remote physical activities adapted to participants' abilities, side effects may include typical exercise-related issues such as muscle soreness or fatigue but should be minimal due to the personalized nature of the programs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are between 18 and 60 years old.
Select...
You are capable of exercising.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Functional capacity from baseline to week 12
Change in the Level of physical activity from baseline to week 12
Feasability/acceptability of the program and Satisfaction
Secondary outcome measures
Changes in the Marin apathy scale from baseline to week 12
Changes in the score of the Fatigue and Daytime Sleepiness Scale from baseline to week 12

Trial Design

1Treatment groups
Experimental Treatment
Group I: Remote activity programExperimental Treatment1 Intervention
Activity program based on objective evaluation. Possibility of 35 different programs primarily targeting impairments (lower limb, upper limb or balanced)

Find a Location

Who is running the clinical trial?

Université du Québec à ChicoutimiLead Sponsor
4 Previous Clinical Trials
234 Total Patients Enrolled
Elise DuchesnePrincipal InvestigatorUniversité du Québec à Chicoutimi

Media Library

Remote activity program Clinical Trial Eligibility Overview. Trial Name: NCT05072288 — N/A
Myotonic Dystrophy Research Study Groups: Remote activity program
Myotonic Dystrophy Clinical Trial 2023: Remote activity program Highlights & Side Effects. Trial Name: NCT05072288 — N/A
Remote activity program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05072288 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be a volunteer participant in this research endeavor?

"This particular clinical trial seeks 40 individuals with myotonic dystrophy, type 1 (dm1) who have reached the age of majority and are under 60 years old. Additionally, all potential participants must be able to partake in exercise activities, as well as give informed consent freely and voluntarily."

Answered by AI

How many participants have been accepted into the clinical trial thus far?

"Affirmative. Clinicaltrials.gov's information states that this trial, which was opened on August 11th 2021, is currently recruiting participants. Forty patients are needed to complete the study between two trial sites."

Answered by AI

Are there any vacancies available in this trial for participants?

"Affirmative. The data hosted on clinicaltrials.gov suggests that this medical study, which was originally posted on August 11th 2021, is actively recruiting patients. Approximately 40 participants need to be sourced from 2 centres of care."

Answered by AI

Does this medical study encompass geriatric patients?

"Eligible applicants for this medical trial must be between 18 and 60 years of age. However, there are 3 distinct trials available to minors and 8 tailored towards seniors over 65."

Answered by AI
Recent research and studies
~11 spots leftby Mar 2025